Table I.
Baseline characteristics
| Characteristics | Intervention group (n = 14) | Control group (n = 14) | |
|---|---|---|---|
| Demographic | Sex, female, n (%) | 11 (78.6) | 12 (85.7) |
| Age, years, mean (SD) | 39.7 (6.7) | 42.3 (5.7) | |
| Education, years, mean (SD) | 14.6 (2.2) | 13.8 (2.5) | |
| Disease and treatment | Multiple sclerosis type (n) | Relapsing remitting (14) | Relapsing remitting (14) |
| Disease duration, years, mean (SD) | 8.4 (6.1) | 14.8 (4.5) | |
| Disease-modifying drug (n) | Fingolimod (14) | Fingolimod (14) | |
| Clinical outcomes | Expanded Disability Status Scale, median (range) | 2.5 (1.0-6.5) | 3.0 (1.0-6.0) |
| Timed 25-Foot Walking Test, s, median (range) | 5.9 (4.32-9.32) | 5.8 (3.98-11.42) | |
SD: standard deviation.